Skip to content
Brand AI

Shenzhen Chipscreen Biosciences Co.

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2022

    Akeso and Chipscreen announce clinical-trial collaboration

    Akeso announced a collaboration agreement with Shenzhen Chipscreen Biosciences to conduct a Phase Ib/II clinical study of Cadonilimab combined with Chiauranib in patients with extensive-stage small-cell lung cancer.

    Source